Mylan Races To Launch Generic Norvasc

Law360 (March 23, 2007, 12:00 AM EDT) -- Just a day after a court ruled its rival’s patent invalid, Mylan Laboratories has rushed to launch a generic version of Pfizer Inc’s blockbuster drug Norvasc.

With no time wasted, Mylan launched three strengths of its amlodipine besylate tablets Friday and triggered its 180-day exclusivity.

The pharmaceutical company was the first generic drug maker to file an application for a cheap version of Pfizer’s popular blood pressure drug.

Although it lost its patent challenge against Pfizer some months ago, a second attempt to challenge the patent...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.